VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

aragon

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 79 out of 100

  • Other
Open relationship map
Claim, correct or request removal

Record updated 18 September 2026

About

Aragon is creating a new class of nuclear receptor targeting drugs that overcome the biology of hormone resistant cancers. Aragon was acquired by Johnson & Johnson in August 2013 for up to $1B.

About the company

Status notes
Aragon was acquired by Johnson & Johnson in August 2013 for up to $1B.

Exit

Acquisition
$1B, 2013-08up to $1B
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy